Literature DB >> 24510827

Managing local swelling following intratumoral electro-chemo-gene therapy.

Jeffry Cutrera1, Glenn King, Pamela Jones, Elias Gumpel, Xueqing Xia, Shulin Li.   

Abstract

Delivering genes and other materials directly into the tumor tissue causes specifically localized and powerfully enhanced efficacy of treatments; however, these specific effects can cause rapid, drastic changes in the appearance, texture, and consistency of the tumor. These changes complicate clinical response measurements which can confound the results and render recurring treatments difficult to perform and clinical response measurements nearly impossible to obtain accurately. One of the complicating issues is local swelling. Here, we demonstrate how swelling caused by intratumoral gene treatments can confound the clinical results and impede further treatments, and we demonstrate an easy technique to help overcome this potential hurdle.

Entities:  

Mesh:

Year:  2014        PMID: 24510827      PMCID: PMC4098855          DOI: 10.1007/978-1-4614-9632-8_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Electrochemotherapy: progress and prospects.

Authors:  Jean-Michel Escoffre; Marie-Pierre Rols
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Regression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogenetherapy.

Authors:  Marina N Torrero; William G Henk; Shulin Li
Journal:  Clin Cancer Res       Date:  2006-01-01       Impact factor: 12.531

3.  Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs.

Authors:  S D Reed; A Fulmer; J Buckholz; B Zhang; J Cutrera; K Shiomitsu; S Li
Journal:  Cancer Gene Ther       Date:  2010-02-12       Impact factor: 5.987

4.  Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response.

Authors:  M Coleman; S Muller; A Quezada; S K Mendiratta; J Wang; N M Thull; J Bishop; M Matar; J Mester; F Pericle
Journal:  Hum Gene Ther       Date:  1998-10-10       Impact factor: 5.695

5.  Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.

Authors:  Jeffry Cutrera; Marina Torrero; Keijiro Shiomitsu; Neal Mauldin; Shulin Li
Journal:  Methods Mol Biol       Date:  2008

6.  The DNA cleavage mechanism of iron-bleomycin. Kinetic resolution of strand scission from base propenal release.

Authors:  R M Burger; S J Projan; S B Horwitz; J Peisach
Journal:  J Biol Chem       Date:  1986-12-05       Impact factor: 5.157

  6 in total
  1 in total

1.  Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapy.

Authors:  Jeffry Cutrera; Glenn King; Pamela Jones; Kristin Kicenuik; Elias Gumpel; Xueqing Xia; Shulin Li
Journal:  J Cell Mol Med       Date:  2015-01-27       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.